-
1
-
-
0032104572
-
Caffeine: An atypical drag of dependence
-
Daly JW, Fredholm BB. Caffeine: an atypical drag of dependence. Drug Alcohol Depend. 1998;51:199-206.
-
(1998)
Drug Alcohol Depend
, vol.51
, pp. 199-206
-
-
Daly, J.W.1
Fredholm, B.B.2
-
2
-
-
0026730694
-
Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects
-
Nehlig A, Daval J-L, Denry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17:139-170.
-
(1992)
Brain Res Brain Res Rev.
, vol.17
, pp. 139-170
-
-
Nehlig, A.1
Daval, J.-L.2
Denry, G.3
-
3
-
-
0345561561
-
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
-
Fredholm BB, Bättig K, Holmèn J, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Phamacol Rev. 1999;51:83-133.
-
(1999)
Phamacol Rev.
, vol.51
, pp. 83-133
-
-
Fredholm, B.B.1
Bättig, K.2
Holmèn, J.3
-
4
-
-
0002424855
-
Mechanism of action of caffeine
-
Garattini S, ed. New York, NY: Raven Press
-
Daly JW. Mechanism of action of caffeine. In: Garattini S, ed. Caffeine, Coffee, and Health. New York, NY: Raven Press; 1993:97-150.
-
(1993)
Caffeine, Coffee, and Health
, pp. 97-150
-
-
Daly, J.W.1
-
6
-
-
0031931065
-
Comparative pharmacology of human adenosine receptor subtypes: Characterization of stably transfected receptors in CHO cells
-
Klotz K-N, Hessling J, Hegler J, et al. Comparative pharmacology of human adenosine receptor subtypes: characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 1998; 357:1-9.
-
(1998)
Naunyn Schmiedebergs Arch Pharmacol.
, vol.357
, pp. 1-9
-
-
Klotz, K.-N.1
Hessling, J.2
Hegler, J.3
-
7
-
-
0028859662
-
Adenosine, adenosine receptors and the actions of caffeine
-
Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76:93-101.
-
(1995)
Pharmacol Toxicol.
, vol.76
, pp. 93-101
-
-
Fredholm, B.B.1
-
9
-
-
0028833513
-
Pharmacological rationale for the clinical use of caffeine
-
Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs. 1995;49:37-50.
-
(1995)
Drugs
, vol.49
, pp. 37-50
-
-
Sawynok, J.1
-
10
-
-
0025153630
-
Coffee, caffeine, and cardiovascular disease in men
-
Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323:1026-1032.
-
(1990)
N Engl J Med.
, vol.323
, pp. 1026-1032
-
-
Grobbee, D.E.1
Rimm, E.B.2
Giovannucci, E.3
-
11
-
-
0344267654
-
The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials
-
Jee SH, He J, Whelton PK, et al. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 1999;33:647-652.
-
(1999)
Hypertension
, vol.33
, pp. 647-652
-
-
Jee, S.H.1
He, J.2
Whelton, P.K.3
-
12
-
-
0013189870
-
Coffee and myocardial infarction: Review of epidemiological evidence
-
Garattini S, ed. New York, NY: Raven Press
-
Franceschi S. Coffee and myocardial infarction: review of epidemiological evidence. In: Garattini S, ed. Caffeine, Coffee, and Health. New York, NY: Raven Press; 1993:195-211.
-
(1993)
Caffeine, Coffee, and Health
, pp. 195-211
-
-
Franceschi, S.1
-
13
-
-
0342844617
-
Coffee and cardiovascular diseases
-
Garattini S, ed. New York, NY: Raven Press
-
Heyden S. Coffee and cardiovascular diseases. In: Garattini S, ed. Caffeine, Coffee, and Health. New York, NY: Raven Press; 1993: 177-193.
-
(1993)
Caffeine, Coffee, and Health
, pp. 177-193
-
-
Heyden, S.1
-
14
-
-
0026009994
-
Caffeine and theophylline as adenosine receptor antagonists in humans
-
Biaggioni I, Paul S, Puckett A, et al. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther. 1991; 258:588-593.
-
(1991)
J Pharmacol Exp Ther.
, vol.258
, pp. 588-593
-
-
Biaggioni, I.1
Paul, S.2
Puckett, A.3
-
15
-
-
0033580489
-
2A adenosine receptors and their function in human platelets
-
2A adenosine receptors and their function in human platelets. Circulation. 1999;99: 2499-2502.
-
(1999)
Circulation
, vol.99
, pp. 2499-2502
-
-
Varani, K.1
Portaluppi, F.2
Merighi, S.3
-
18
-
-
0019061918
-
Ligand: A versatile computerized approach for the characterization of ligand binding systems
-
Munson PJ, Rodbard D. Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem. 1980;107: 220-239.
-
(1980)
Anal Biochem.
, vol.107
, pp. 220-239
-
-
Munson, P.J.1
Rodbard, D.2
-
20
-
-
78651139188
-
The aggregation of blood platelets
-
Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol. 1963;168:178-195.
-
(1963)
J Physiol.
, vol.168
, pp. 178-195
-
-
Born, G.V.R.1
Cross, M.J.2
-
22
-
-
0025368965
-
Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: Evidence that both effects are coupled to adenylate cyclase
-
Paul S, Feoktistov I, Hollister AS, et al. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol Pharmacol. 1990;37:870-875.
-
(1990)
Mol Pharmacol.
, vol.37
, pp. 870-875
-
-
Paul, S.1
Feoktistov, I.2
Hollister, A.S.3
-
23
-
-
0027448029
-
Locomotor activity in mice during chronic treatment with caffeine and withdrawal
-
Nikodijevi O, Jacobsen KA, Daly JW. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol Biochem Behav. 1993;44:199-216.
-
(1993)
Pharmacol Biochem Behav.
, vol.44
, pp. 199-216
-
-
Nikodijevi, O.1
Jacobsen, K.A.2
Daly, J.W.3
-
27
-
-
1842407192
-
Caffeine alters plasma adenosine levels
-
Conlay AL, Conant AJ, deBros F, et al. Caffeine alters plasma adenosine levels. Nature. 1997;389:136.
-
(1997)
Nature
, vol.389
, pp. 136
-
-
Conlay, A.L.1
Conant, A.J.2
DeBros, F.3
|